InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,716.10
(
0.24%
)
US TECH 100
19,309.60
(
0.06%
)
Dow Jones
42,112.36
(
0.12%
)
Brent Oil
73.45
(
-0.60%
)
Bitcoin
63,379.58
(
-0.38%
)
Post# of 116668
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

wadegarret

Send PM Follow Ignore
Followers 123
Posts 29411
Boards Moderated 2
Alias Born 10/04/2004

wadegarret

Member Level

Re: None

Thursday, 09/17/2020 12:35:52 PM

Thursday, September 17, 2020 12:35:52 PM

Post# of 116668
HZNP($76.50) looks cheap IMO

JP Morgan upgraded to $110 target, and the average target is now around $100. I see the stock as a good hold till at least $100, but could very well be a good long term hold. It all depends on their latest drug Tepezza, which is supposed to bring in $2B+/year starting 2021. Also their gout drug Krystexxa is growing revenues strong yoy & doing around $500M/year now. I believe a 20+ PE going forward is warranted on this one, and that would take the stock to well over $100 if the company comes through on Tepezza. With the recent offering at $71, I believe that sets a floor on the stock, so little downside risk IMO.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up